Table 1—

Most frequent adverse events with incidence ≥10% in any treatment arm (ITT)*

Preferred termPlacebo5 μg exenatide10 μg exenatide
n247245241
Nausea51 (20.6)96 (39.2)117 (48.5)
Hypoglycemia31 (12.6)47 (19.2)67 (27.8)
Upper respiratory tract infection48 (19.4)28 (11.4)42 (17.4)
Vomiting11 (4.5)36 (14.7)33 (13.7)
Diarrhea16 (6.5)25 (10.2)42 (17.4)
Feeling jittery17 (6.9)21 (8.6)28 (11.6)
Headache12 (4.9)27 (11.0)18 (7.5)
  • Data are n (%).

  • *

    * Treatment emergent.